These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30238240)

  • 1. Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau.
    Courade JP; Angers R; Mairet-Coello G; Pacico N; Tyson K; Lightwood D; Munro R; McMillan D; Griffin R; Baker T; Starkie D; Nan R; Westwood M; Mushikiwabo ML; Jung S; Odede G; Sweeney B; Popplewell A; Burgess G; Downey P; Citron M
    Acta Neuropathol; 2018 Nov; 136(5):729-745. PubMed ID: 30238240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
    Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
    Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo.
    Vandermeeren M; Borgers M; Van Kolen K; Theunis C; Vasconcelos B; Bottelbergs A; Wintmolders C; Daneels G; Willems R; Dockx K; Delbroek L; Marreiro A; Ver Donck L; Sousa C; Nanjunda R; Lacy E; Van De Casteele T; Van Dam D; De Deyn PP; Kemp JA; Malia TJ; Mercken MH
    J Alzheimers Dis; 2018; 65(1):265-281. PubMed ID: 30040731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils.
    Marreiro A; Van Kolen K; Sousa C; Temmerman L; Vasconcelos B; Crespo-Rodriguez R; van Weering JRT; Van Dam D; De Deyn PP; Apetri A; Schoofs L; Mercken MH
    BMC Mol Cell Biol; 2020 Nov; 21(1):81. PubMed ID: 33183222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau epitope display in progressive supranuclear palsy and corticobasal degeneration.
    Berry RW; Sweet AP; Clark FA; Lagalwar S; Lapin BR; Wang T; Topgi S; Guillozet-Bongaarts AL; Cochran EJ; Bigio EH; Binder LI
    J Neurocytol; 2004 May; 33(3):287-95. PubMed ID: 15475684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phosphorylation-Induced Turn Defines the Alzheimer's Disease AT8 Antibody Epitope on the Tau Protein.
    Gandhi NS; Landrieu I; Byrne C; Kukic P; Amniai L; Cantrelle FX; Wieruszeski JM; Mancera RL; Jacquot Y; Lippens G
    Angew Chem Int Ed Engl; 2015 Jun; 54(23):6819-23. PubMed ID: 25881502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer's Disease and Primary Tauopathy Postmortem Brains.
    Helboe L; Rosenqvist N; Volbracht C; Pedersen LØ; Pedersen JT; Christensen S; Egebjerg J; Christoffersen CT; Bang-Andersen B; Beach TG; Serrano GE; Falsig J
    J Alzheimers Dis; 2022; 88(1):207-228. PubMed ID: 35570492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
    Combs B; Hamel C; Kanaan NM
    Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice.
    Dai CL; Hu W; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2018 Jan; 10(1):13. PubMed ID: 29386065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease.
    Roberts M; Sevastou I; Imaizumi Y; Mistry K; Talma S; Dey M; Gartlon J; Ochiai H; Zhou Z; Akasofu S; Tokuhara N; Ogo M; Aoyama M; Aoyagi H; Strand K; Sajedi E; Agarwala KL; Spidel J; Albone E; Horie K; Staddon JM; de Silva R
    Acta Neuropathol Commun; 2020 Feb; 8(1):13. PubMed ID: 32019610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy.
    Congdon EE; Lin Y; Rajamohamedsait HB; Shamir DB; Krishnaswamy S; Rajamohamedsait WJ; Rasool S; Gonzalez V; Levenga J; Gu J; Hoeffer C; Sigurdsson EM
    Mol Neurodegener; 2016 Aug; 11(1):62. PubMed ID: 27578006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation determines the seeding potencies of native and recombinant Tau aggregates.
    Falcon B; Cavallini A; Angers R; Glover S; Murray TK; Barnham L; Jackson S; O'Neill MJ; Isaacs AM; Hutton ML; Szekeres PG; Goedert M; Bose S
    J Biol Chem; 2015 Jan; 290(2):1049-65. PubMed ID: 25406315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser
    van Ameijde J; Crespo R; Janson R; Juraszek J; Siregar B; Verveen H; Sprengers I; Nahar T; Hoozemans JJ; Steinbacher S; Willems R; Delbroek L; Borgers M; Dockx K; Van Kolen K; Mercken M; Pascual G; Koudstaal W; Apetri A
    Acta Neuropathol Commun; 2018 Jul; 6(1):59. PubMed ID: 30001207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro.
    Nobuhara CK; DeVos SL; Commins C; Wegmann S; Moore BD; Roe AD; Costantino I; Frosch MP; Pitstick R; Carlson GA; Hock C; Nitsch RM; Montrasio F; Grimm J; Cheung AE; Dunah AW; Wittmann M; Bussiere T; Weinreb PH; Hyman BT; Takeda S
    Am J Pathol; 2017 Jun; 187(6):1399-1412. PubMed ID: 28408124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau Antibody Structure Reveals a Molecular Switch Defining a Pathological Conformation of the Tau Protein.
    Chukwu JE; Pedersen JT; Pedersen LØ; Volbracht C; Sigurdsson EM; Kong XP
    Sci Rep; 2018 Apr; 8(1):6209. PubMed ID: 29670132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy.
    Kondo A; Shahpasand K; Mannix R; Qiu J; Moncaster J; Chen CH; Yao Y; Lin YM; Driver JA; Sun Y; Wei S; Luo ML; Albayram O; Huang P; Rotenberg A; Ryo A; Goldstein LE; Pascual-Leone A; McKee AC; Meehan W; Zhou XZ; Lu KP
    Nature; 2015 Jul; 523(7561):431-436. PubMed ID: 26176913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteopathic tau seeding predicts tauopathy in vivo.
    Holmes BB; Furman JL; Mahan TE; Yamasaki TR; Mirbaha H; Eades WC; Belaygorod L; Cairns NJ; Holtzman DM; Diamond MI
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):E4376-85. PubMed ID: 25261551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.